The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nalbuphine HCL Market Research Report 2024
Synopsis
Nalbuphine HCL (Nalbuphine hydrochloride) is a narcotic pain reliever used to treat moderate to severe pain.Nubain is also used for treating pain just after surgery or childbirth.
The global Nalbuphine HCL market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nalbuphine HCL is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nalbuphine HCL is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nalbuphine HCL include Acme, Dr Reddy's, Glenmark, Global Pharmaceuticals, HOSPIRA, Humanwell, Incepta Pharmaceuticals, Manusaktteva and Opsonin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nalbuphine HCL, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nalbuphine HCL.
Report Scope
The Nalbuphine HCL market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nalbuphine HCL market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nalbuphine HCL manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acme
Dr Reddy's
Glenmark
Global Pharmaceuticals
HOSPIRA
Humanwell
Incepta Pharmaceuticals
Manusaktteva
Opsonin
Sami
Squarepharma
Segment by Type
Adult
Children
Segment by Application
Hospital
Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nalbuphine HCL manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nalbuphine HCL in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nalbuphine HCL (Nalbuphine hydrochloride) is a narcotic pain reliever used to treat moderate to severe pain.Nubain is also used for treating pain just after surgery or childbirth.
The global Nalbuphine HCL market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nalbuphine HCL is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nalbuphine HCL is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nalbuphine HCL include Acme, Dr Reddy's, Glenmark, Global Pharmaceuticals, HOSPIRA, Humanwell, Incepta Pharmaceuticals, Manusaktteva and Opsonin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nalbuphine HCL, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nalbuphine HCL.
Report Scope
The Nalbuphine HCL market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nalbuphine HCL market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nalbuphine HCL manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acme
Dr Reddy's
Glenmark
Global Pharmaceuticals
HOSPIRA
Humanwell
Incepta Pharmaceuticals
Manusaktteva
Opsonin
Sami
Squarepharma
Segment by Type
Adult
Children
Segment by Application
Hospital
Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nalbuphine HCL manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nalbuphine HCL in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nalbuphine HCL Market Overview
1.1 Product Overview and Scope of Nalbuphine HCL
1.2 Nalbuphine HCL Segment by Type
1.2.1 Global Nalbuphine HCL Market Value Comparison by Type (2024-2030)
1.2.2 Adult
1.2.3 Children
1.3 Nalbuphine HCL Segment by Application
1.3.1 Global Nalbuphine HCL Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Nalbuphine HCL Market Size Estimates and Forecasts
1.4.1 Global Nalbuphine HCL Revenue 2019-2030
1.4.2 Global Nalbuphine HCL Sales 2019-2030
1.4.3 Global Nalbuphine HCL Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nalbuphine HCL Market Competition by Manufacturers
2.1 Global Nalbuphine HCL Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nalbuphine HCL Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nalbuphine HCL Average Price by Manufacturers (2019-2024)
2.4 Global Nalbuphine HCL Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nalbuphine HCL, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nalbuphine HCL, Product Type & Application
2.7 Nalbuphine HCL Market Competitive Situation and Trends
2.7.1 Nalbuphine HCL Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nalbuphine HCL Players Market Share by Revenue
2.7.3 Global Nalbuphine HCL Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nalbuphine HCL Retrospective Market Scenario by Region
3.1 Global Nalbuphine HCL Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nalbuphine HCL Global Nalbuphine HCL Sales by Region: 2019-2030
3.2.1 Global Nalbuphine HCL Sales by Region: 2019-2024
3.2.2 Global Nalbuphine HCL Sales by Region: 2025-2030
3.3 Global Nalbuphine HCL Global Nalbuphine HCL Revenue by Region: 2019-2030
3.3.1 Global Nalbuphine HCL Revenue by Region: 2019-2024
3.3.2 Global Nalbuphine HCL Revenue by Region: 2025-2030
3.4 North America Nalbuphine HCL Market Facts & Figures by Country
3.4.1 North America Nalbuphine HCL Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nalbuphine HCL Sales by Country (2019-2030)
3.4.3 North America Nalbuphine HCL Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nalbuphine HCL Market Facts & Figures by Country
3.5.1 Europe Nalbuphine HCL Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nalbuphine HCL Sales by Country (2019-2030)
3.5.3 Europe Nalbuphine HCL Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nalbuphine HCL Market Facts & Figures by Country
3.6.1 Asia Pacific Nalbuphine HCL Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nalbuphine HCL Sales by Country (2019-2030)
3.6.3 Asia Pacific Nalbuphine HCL Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nalbuphine HCL Market Facts & Figures by Country
3.7.1 Latin America Nalbuphine HCL Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nalbuphine HCL Sales by Country (2019-2030)
3.7.3 Latin America Nalbuphine HCL Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nalbuphine HCL Market Facts & Figures by Country
3.8.1 Middle East and Africa Nalbuphine HCL Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nalbuphine HCL Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nalbuphine HCL Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nalbuphine HCL Sales by Type (2019-2030)
4.1.1 Global Nalbuphine HCL Sales by Type (2019-2024)
4.1.2 Global Nalbuphine HCL Sales by Type (2025-2030)
4.1.3 Global Nalbuphine HCL Sales Market Share by Type (2019-2030)
4.2 Global Nalbuphine HCL Revenue by Type (2019-2030)
4.2.1 Global Nalbuphine HCL Revenue by Type (2019-2024)
4.2.2 Global Nalbuphine HCL Revenue by Type (2025-2030)
4.2.3 Global Nalbuphine HCL Revenue Market Share by Type (2019-2030)
4.3 Global Nalbuphine HCL Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nalbuphine HCL Sales by Application (2019-2030)
5.1.1 Global Nalbuphine HCL Sales by Application (2019-2024)
5.1.2 Global Nalbuphine HCL Sales by Application (2025-2030)
5.1.3 Global Nalbuphine HCL Sales Market Share by Application (2019-2030)
5.2 Global Nalbuphine HCL Revenue by Application (2019-2030)
5.2.1 Global Nalbuphine HCL Revenue by Application (2019-2024)
5.2.2 Global Nalbuphine HCL Revenue by Application (2025-2030)
5.2.3 Global Nalbuphine HCL Revenue Market Share by Application (2019-2030)
5.3 Global Nalbuphine HCL Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Acme
6.1.1 Acme Corporation Information
6.1.2 Acme Description and Business Overview
6.1.3 Acme Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Acme Nalbuphine HCL Product Portfolio
6.1.5 Acme Recent Developments/Updates
6.2 Dr Reddy's
6.2.1 Dr Reddy's Corporation Information
6.2.2 Dr Reddy's Description and Business Overview
6.2.3 Dr Reddy's Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Dr Reddy's Nalbuphine HCL Product Portfolio
6.2.5 Dr Reddy's Recent Developments/Updates
6.3 Glenmark
6.3.1 Glenmark Corporation Information
6.3.2 Glenmark Description and Business Overview
6.3.3 Glenmark Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glenmark Nalbuphine HCL Product Portfolio
6.3.5 Glenmark Recent Developments/Updates
6.4 Global Pharmaceuticals
6.4.1 Global Pharmaceuticals Corporation Information
6.4.2 Global Pharmaceuticals Description and Business Overview
6.4.3 Global Pharmaceuticals Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Global Pharmaceuticals Nalbuphine HCL Product Portfolio
6.4.5 Global Pharmaceuticals Recent Developments/Updates
6.5 HOSPIRA
6.5.1 HOSPIRA Corporation Information
6.5.2 HOSPIRA Description and Business Overview
6.5.3 HOSPIRA Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.5.4 HOSPIRA Nalbuphine HCL Product Portfolio
6.5.5 HOSPIRA Recent Developments/Updates
6.6 Humanwell
6.6.1 Humanwell Corporation Information
6.6.2 Humanwell Description and Business Overview
6.6.3 Humanwell Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Humanwell Nalbuphine HCL Product Portfolio
6.6.5 Humanwell Recent Developments/Updates
6.7 Incepta Pharmaceuticals
6.6.1 Incepta Pharmaceuticals Corporation Information
6.6.2 Incepta Pharmaceuticals Description and Business Overview
6.6.3 Incepta Pharmaceuticals Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Incepta Pharmaceuticals Nalbuphine HCL Product Portfolio
6.7.5 Incepta Pharmaceuticals Recent Developments/Updates
6.8 Manusaktteva
6.8.1 Manusaktteva Corporation Information
6.8.2 Manusaktteva Description and Business Overview
6.8.3 Manusaktteva Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Manusaktteva Nalbuphine HCL Product Portfolio
6.8.5 Manusaktteva Recent Developments/Updates
6.9 Opsonin
6.9.1 Opsonin Corporation Information
6.9.2 Opsonin Description and Business Overview
6.9.3 Opsonin Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Opsonin Nalbuphine HCL Product Portfolio
6.9.5 Opsonin Recent Developments/Updates
6.10 Sami
6.10.1 Sami Corporation Information
6.10.2 Sami Description and Business Overview
6.10.3 Sami Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sami Nalbuphine HCL Product Portfolio
6.10.5 Sami Recent Developments/Updates
6.11 Squarepharma
6.11.1 Squarepharma Corporation Information
6.11.2 Squarepharma Nalbuphine HCL Description and Business Overview
6.11.3 Squarepharma Nalbuphine HCL Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Squarepharma Nalbuphine HCL Product Portfolio
6.11.5 Squarepharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nalbuphine HCL Industry Chain Analysis
7.2 Nalbuphine HCL Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nalbuphine HCL Production Mode & Process
7.4 Nalbuphine HCL Sales and Marketing
7.4.1 Nalbuphine HCL Sales Channels
7.4.2 Nalbuphine HCL Distributors
7.5 Nalbuphine HCL Customers
8 Nalbuphine HCL Market Dynamics
8.1 Nalbuphine HCL Industry Trends
8.2 Nalbuphine HCL Market Drivers
8.3 Nalbuphine HCL Market Challenges
8.4 Nalbuphine HCL Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
